ZCY-32669-33720
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 840 / UT
- Registered
- 2021-11-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-24
Dose 2 — Pfizer-BioNTech
-
2021-11-18
Registered in v-safe
-
2021-11-18
Dose 3 — Pfizer-BioNTech
-
2021-11-18
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-11-18
Report sent to call center — day 0, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-21
Survey response — days 1–6 daily, dose 3MedDRA: Furuncle, Injection site reaction, Injection site vesicles — Feeling: Fair · Site: Redness, Swelling · Fatigue or tirednessFree text: Blisters or boils at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-11-24
- 2021-11-26
- 2021-12-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | No |
| 2 | 2021-01-24 | Pfizer-BioNTech | No |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-18 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Blisters or boils at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Furuncle | · | · | ✓ |
| SRO | Injection site reaction | · | · | ✓ |
| SRO | Injection site vesicles | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release